The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis

By sjmartinez • February 1, 2024

Xiong YQ, Li Y, Goncheva MI, Elsayed AM, Zhu F, Li L, Abdelhady W, Flannagan RS, Yeaman MR, Bayer AS, Heinrichs DE. The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis. J Infect Dis. 2024 Jan 31:jiad577. doi: 10.1093/infdis/jiad577. Epub ahead of print. PMID: 38297970.

Tags: and endocarditis, Harbor UCLA, Infectious Diseases, Molecular Medicine, MRSA, Publications, purine biosynthesis, VAN Persistence

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Ritz J, Gibbs M, Kouekam HT, Esser MT, Daar ES,[...]

Measuring parameters of aerobic function during exercise: One protocol to rule them all?

Poole DC, Rossiter HB. Measuring parameters of aerobic function during exercise: One protocol to rule them all? Exp Physiol. 2025 Mar 22. doi: 10.1113/EP092732. Epub[...]

SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)

Sábato S, Benet S, Rogers AJ, Murray TA, Skeans M, Mothe B, Paredes R, Mourad A, Kiweewa F, Kamel D, Jain MK, Lutaakome J, Nalubega[...]